Acceptability of Antiretroviral Pre-exposure Prophylaxis from a Cohort of Sexually Experienced Young Transgender Women in Two U.S. Cities

Acceptability of Antiretroviral Pre-exposure Prophylaxis from a Cohort of Sexually Experienced Young Transgender Women in Two U.S. Cities

Emtricitabine/tenofovir disoproxil fumarate as pre-exposure prophylaxis (PrEP) can prevent HIV infection among at-risk individuals, including young transgender women (YTW). We used baseline data from 230 HIV-uninfected YTW (ages 16–29 years) who were enrolled in Project LifeSkills during 2012–2015....

Full description

Bibliographic Details
Main Authors: Garofalo, R. (Author), Kuhns, L. (Author), Mimiaga, M.J (Author), Ogunbajo, A. (Author), Reisner, S.L (Author), Restar, A.J (Author)
Format: Article
Language:English
Published: Springer New York LLC 2018
Subjects:
adolescent
Adolescent
adult
Adult
anti human immunodeficiency virus agent
Anti-HIV Agents
article
Boston
Chicago
Cities
city
cohort analysis
Cohort Studies
controlled study
emtricitabine
Emtricitabine
female
Female
HIV Infections
HIV prevention
human
Human immunodeficiency virus
Human immunodeficiency virus infection
Humans
Illinois
major clinical study
male
Male
Massachusetts
middle aged
Middle Aged
multiple linear regression analysis
nonhuman
Patient Acceptance of Health Care
patient attitude
pre-exposure prophylaxis
Pre-exposure prophylaxis
Pre-Exposure Prophylaxis
psychology
sexual behavior
Sexual Behavior
Sexual Partners
sexuality
statistical significance
statistics and numerical data
tenofovir
Tenofovir
transactional sex
transgender
Transgender Persons
Transgender women
utilization
young adult
Young Adult
Young adults
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items